Liên Minh Châu Âu - Tiếng Slovenia - EMA (European Medicines Agency)

acino ag - klopidogrel - peripheral vascular diseases; acute coronary syndrome; myocardial infarction; stroke - antitrombotična sredstva - clopidogrel is indicated in adults for the prevention of atherothrombotic events in: , , , patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease, non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa), st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy, patients suffering from acute coronary syndrome. , ,.

Liên Minh Châu Âu - Tiếng Slovenia - EMA (European Medicines Agency)

viatris limited - klopidogrel besilat - peripheral vascular diseases; stroke; myocardial infarction - antitrombotična sredstva - secondary prevention of atherothrombotic events clopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. adult patients suffering from acute coronary syndrome. non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). st segmentu višinskih akutni miokardni infarkt, v kombinaciji s asa v medicinsko zdravljenih bolnikih, ki izpolnjujejo pogoje za thrombolytic terapija. in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is) clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. prevention of atherothrombotic and thromboembolic events in atrial fibrillation:in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. za nadaljnje informacije, prosimo, preberite razdelek 5.

Liên Minh Châu Âu - Tiếng Slovenia - EMA (European Medicines Agency)

teva pharma b.v. - clopidogrel (as hydrochloride) - peripheral vascular diseases; acute coronary syndrome; myocardial infarction; stroke - antitrombotična sredstva - clopidogrel je navedeno pri odraslih za preprečevanje atherothrombotic dogodkov v:bolnike, ki trpijo za miokardni infarkt (od nekaj dni do manj kot 35 dni), ischaemic kap (od 7 dni do manj kot 6 mesecev) ali sedež periferne arterijske bolezni. patients suffering from acute coronary syndrome:non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). st segmentu višinskih akutni miokardni infarkt, v kombinaciji s asa v medicinsko zdravljenih bolnikih, ki izpolnjujejo pogoje za thrombolytic terapija. za nadaljnje informacije, prosimo, preberite razdelek 5.

Liên Minh Châu Âu - Tiếng Slovenia - EMA (European Medicines Agency)

sanofi winthrop industrie - klopidogrel vodikov sulfat - stroke; peripheral vascular diseases; atrial fibrillation; myocardial infarction; acute coronary syndrome - antitrombotična sredstva - secondary prevention of atherothrombotic eventsclopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from seven days until less than six months) or established peripheral arterial disease;adult patients suffering from acute coronary syndrome:non-st-segment-elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa);st-segment-elevation acute myocardial infarction, in combination with asa in patients undergoing percutaneous coronary intervention (including patients undergoing a stent replacement) or medically treated patients eligible for thrombolytic/fibrinolytic therapy. in patients with moderate to high-risk transient ischemic attack (tia) or minor ischemic stroke (is)clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2  score ≥4) or minor is (nihss  ≤3) within 24 hours of either the tia or is event. preprečevanje atherothrombotic in thromboembolic dogodkov v atrijska fibrillationin odraslih bolnikov z atrijsko fibrilacijo, ki imajo vsaj en dejavnik tveganja za žilne dogodke, niso primerni za zdravljenje z vitaminom k antagonisti in ki imajo nizko tveganje krvavitve, clopidogrel je indiciran v kombinaciji s asa za preprečevanje atherothrombotic in thromboembolic dogodkov, vključno z možgansko kap.

Slovenia - Tiếng Slovenia - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

ibuprofen - peroralna suspenzija - ibuprofen 40 mg / 1 ml - ibuprofen

Slovenia - Tiếng Slovenia - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lek d.d. - acetilsalicilna kislina - gastrorezistentna tableta - acetilsalicilna kislina 75 mg / 1 tableta - acetilsalicilna kislina

Slovenia - Tiếng Slovenia - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

lek d.d. - acetilsalicilna kislina - gastrorezistentna tableta - acetilsalicilna kislina 75 mg / 1 tableta - acetilsalicilna kislina

Slovenia - Tiếng Slovenia - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

acetilsalicilna kislina; rosuvastatin - kapsula, trda - acetilsalicilna kislina 100 mg / 1 kapsula  rosuvastatin10 mg / 1 kapsula; rosuvastatin 10 mg / 1 kapsula - rosuvastatin in acetilsalicilna kislina

Slovenia - Tiếng Slovenia - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

acetilsalicilna kislina; rosuvastatin - kapsula, trda - acetilsalicilna kislina 100 mg / 1 kapsula  rosuvastatin20 mg / 1 kapsula; rosuvastatin 20 mg / 1 kapsula - rosuvastatin in acetilsalicilna kislina

Slovenia - Tiếng Slovenia - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

acetilsalicilna kislina; rosuvastatin - kapsula, trda - acetilsalicilna kislina 100 mg / 1 kapsula  rosuvastatin5 mg / 1 kapsula; rosuvastatin 5 mg / 1 kapsula - rosuvastatin in acetilsalicilna kislina